Investigation of the antioxidant status in multiple myeloma patients: effects of therapy

Asian Pac J Cancer Prev. 2013;14(6):3663-7. doi: 10.7314/apjcp.2013.14.6.3663.

Abstract

Background: Multiple myeloma is a malignant silent incurable plasma cell disorder. The present study aimed to assessed the activation of the oxidative stress pathway in affected patients.

Materials and methods: Advanced oxidation protein products (AOPPs), malondialdehyde (MDA), adenosine deaminase (ADA), total antioxidant capacity (TAC) levels, glutathione, ascorbic acid (vitamin C), α-tocopherol (vitamin E) in addition to related enzymes glutathione peroxidase (GSH-Px), glutathione reductase (GSH-R) and superoxide dismutase (SOD) were analyzed in sixty patients with multiple myeloma before and after one month treatment with induction therapy.

Results: The results of the study showed a significant elevation in AOPPs, MDA, ADA levels in patients with multiple myeloma before and after treatment in comparison to healthy control samples In contrast TAC glutathione, vitamin C and E, and the antioxidant enzymes levels were decreased significantly. On comparing samples of MM patients after treatment, there was significant increase of TAC glutathione, vitamin C and E, and the antioxidant enzymes in parallel with decreasing AOPPs, MDA and ADA levels in comparison with samples of patients before treatment.

Conclusions: The results indicate oxidative stress and DNA damage activity increase in MM and are alleviated in response to therapy.

Publication types

  • Comparative Study

MeSH terms

  • Adenosine Deaminase / blood
  • Advanced Oxidation Protein Products / blood
  • Antioxidants / metabolism*
  • Ascorbic Acid / blood
  • Biomarkers / blood*
  • Case-Control Studies
  • Combined Modality Therapy
  • Female
  • Follow-Up Studies
  • Glutathione / blood
  • Glutathione Peroxidase / blood
  • Glutathione Reductase / blood
  • Humans
  • Male
  • Malondialdehyde / blood
  • Middle Aged
  • Multiple Myeloma / blood*
  • Multiple Myeloma / therapy*
  • Prognosis
  • Superoxide Dismutase / blood
  • Vitamin E / blood
  • alpha-Tocopherol / blood

Substances

  • Advanced Oxidation Protein Products
  • Antioxidants
  • Biomarkers
  • Vitamin E
  • Malondialdehyde
  • Glutathione Peroxidase
  • Superoxide Dismutase
  • Glutathione Reductase
  • Adenosine Deaminase
  • Glutathione
  • alpha-Tocopherol
  • Ascorbic Acid